Skip to main content
padlock icon - secure page this page is secure

Focal fluorine-18 fluorodeoxyglucose-avid parotid findings in patients with lung cancer: prevalence and characteristics

Buy Article:

$52.00 + tax (Refund Policy)

Objective

Correct interpretation of incidental tumors is important to plan an appropriate treatment. We assessed the incidence and imaging characteristics of fluorine-18 fluorodeoxyglucose (18F-FDG)-avid focal parotid findings (FPFs) in patients with lung cancer.

Patients and methods

FPFs in PET-computed tomography reports of cancer patients were searched. Those with known parotid malignancies, lymphoma, and diffuse 18F-FDG uptake in the entire parotid gland were not included in the analysis.

Results

FPFs were detected in 38/3120 cancer patients (1.23%), observed as a soft tissue mass with a mean diameter 1.6±0.5 cm (range 0.8–2.7 cm) and a mean maximum standardized uptake value of 7.7±3.7 (range 2.5–17.8). FPFs were observed in 23/604 (3.8%) patients with lung cancer, compared with 6/1366 (0.4%) with breast cancer and 5/842 (0.6%) with gastrointestinal malignancies. We assessed FPFs appearances in 23 patients with lung cancer (18 men, mean age 72.8±9.2); 20 (87%) were current or past smokers. There was no correlation between the stage or histopathological type of the lung cancer and the prevalence of parotid lesions. In four patients with histopathology, no malignancy was detected. For an additional 11 patients with available imaging and clinical follow-up (mean follow-up 15.5±13.5 months, range 3–42 months), FPFs were consistent with benign lesions.

Conclusion

FPFs were more prevalent among patients with lung cancer than in patients with other malignancies. As 18F-FDG avidity was moderate to high, FPFs may mimic distant metastases. It is important to consider FPFs in the interpretation of a focal parotid lesion as misinterpretation may result in denial of appropriate therapy.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: 18F-FDG PET-CT; lung cancer; parotid

Document Type: Research Article

Affiliations: 1: Departments of Nuclear Medicine, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel 2: Diagnostic Imaging 3: Pathology, Chaim Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel 4: Division of Surgery, Assaf Harofeh Medical Center, Zerifin 5: Division of Surgery, Assaf Harofeh Medical Center, Zerifin, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel 6: Departments of Nuclear Medicine, Institute of Nuclear Medicine, University College London and UCL Hospitals, London, UK

Publication date: September 1, 2016

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more